McKesson’s Matthew Zubiller to Discuss Z-Code Identifiers at 5th Annual Personalized Medicine Con

BOSTON - May 31, 2013 - PRLog -- Matthew Zubiller Decision Management Executive at Mckesson will discuss Understanding the Value of Advanced Diagnostics: Aligning Labs, Clinicians and Payers to Make Better Decisions at the 5th Annual Personalized Medicine Conference in Boston, MA on October 21 & 22. 2013.

Today, over 3000 molecular diagnostic (MDx) tests are marketed for clinical use and new diagnostics are regularly emerging at a rate of several per month. No standardized system for uniquely identifying these tests or capturing and analyzing the clinical and financial impact of individual tests currently exists. This discussion will show how the coordinated effort between the AMA and McKesson will bring specificity to the use, identification, reporting and tracking of MDx tests through a mapping of AMA CPT® codes to McKesson Z-Code™ Identifiers. This coordinated process will help to improve communication and collaboration between clinicians, hospitals, labs and payers

As an official satellite event to the American Society of Human Genetics ASHG 2013 Annual Meeting, the 5th Annual Personalized Medicine Conference is anticipated to see record attendance levels. This two day event is one of the most highly regarded Personalized Medicine conferences in the United States, attracting  clinicians, developers of molecular diagnostics, biopharmaceutical professionals, geneticists and investors  from around the world  to discuss the rapidly advancing field of Personalized Medicine. Visit www.personalized-medicine-conference.com for more information.